Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers

Published:2019-12 Issue: Volume:216 Page:51-62
ISSN:0165-2478
Container-title:Immunology Letters
language:en
Short-container-title:Immunology Letters

Author:

Chen Lei,Qiao Dongjuan,Wang Juntao,Tian Geng,Wang Mingjun

Funder

Shenzhen Peacock Plan

Shenzhen Basic Research Program

Special Funds for Dapeng New District Industry Development

Natural Science Foundation of Guangdong Province

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference110 articles.

1. Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients;Dudley;J. Immunother.,2003

2. Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy;Tran;J. Immunother.,2008

3. Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy;Rosenberg;Clin. Cancer Res.,2011

4. Industrializing autologous adoptive immunotherapies: manufacturing advances and challenges;Iyer;Front. Med. (Lausanne),2018

5. Pursuit of tumor-infiltrating lymphocyte immunotherapy speeds up;Garber;Nat. Biotechnol.,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production;Cellular Immunology;2024-09

2. Tumor Microenvironment Composition and Related Therapy in Hepatocellular Carcinoma;Journal of Hepatocellular Carcinoma;2023-11

3. New insights for gynecological cancer therapies: from molecular mechanisms and clinical evidence to future directions;Cancer and Metastasis Reviews;2023-06-27

4. Receptors of immune cells mediates recognition for tumors;Progress in Molecular Biology and Translational Science;2023

5. Efficacy of pp65‐specific TCR‐T cell therapy in treating cytomegalovirus infection after hematopoietic stem cell transplantation;American Journal of Hematology;2022-09-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3